In this study, we provide evidence for the first time that two CDYL2 transcript variants, named CDYL2a and CDYL2b, are predominantly expressed in human breast cancer cell lines and primary breast tumors and exert discrete functions in breast cancer growth and metastasis. The gene discussed is CDYL2; the disease is breast carcinoma.